Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amgen (NQ: AMGN ) 316.23 +3.37 (+1.08%) Streaming Delayed Price Updated: 10:14 AM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 509,086 Open 313.68 Bid (Size) 315.99 (2) Ask (Size) 316.54 (2) Prev. Close 312.86 Today's Range 313.37 - 317.76 52wk Range 249.70 - 346.85 Shares Outstanding N/A Dividend Yield 2.69% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Taiwan Semiconductor, American Tower, Trane Technologies And A Health Care Stock On CNBC's 'Final Trades' Today 8:32 EDT Analyst Stephen Weiss of Short Hills Capital Partners said he still finds Taiwan Semiconductor Manufacturing Company cheap. Via Benzinga Analyst Expectations For Amgen's Future September 25, 2024 Via Benzinga Performance YTD +6.34% +6.34% 1 Month -3.23% -3.23% 3 Month +1.09% +1.09% 6 Month +10.45% +10.45% 1 Year +17.54% +17.54% More News Read More Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs September 25, 2024 Via Benzinga Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases September 25, 2024 Via Investor's Business Daily Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market September 25, 2024 Via Benzinga Market Whales and Their Recent Bets on AMGN Options September 24, 2024 Via Benzinga What the Options Market Tells Us About Amgen September 23, 2024 Via Benzinga Interesting Technical Analysis finding for AMGEN INC (NASDAQ:AMGN) September 20, 2024 Via Chartmill Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday? September 24, 2024 Via Benzinga 2 Weight-Loss Stocks That Could Rocket Higher This Year September 24, 2024 Via The Motley Fool Tesla Leads S&P 500 Index, While Biotech Giant Tumbles On Court Ruling September 23, 2024 Via Investor's Business Daily Topics Stocks Exposures US Equities Regeneron Dives As Amgen Tees Up Its Rival To Moneymaking Machine Eylea September 23, 2024 Via Investor's Business Daily Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy? September 23, 2024 Via The Motley Fool Where Will Amgen Be in 5 Years? September 20, 2024 Via The Motley Fool Behind the Scenes of Amgen's Latest Options Trends September 19, 2024 Via Benzinga Can These 5 Assets Skyrocket Your Portfolio? September 22, 2024 Via Talk Markets Topics ETFs Stocks Exposures US Equities 10 Health Care Stocks With Whale Alerts In Today's Session September 18, 2024 Via Benzinga The Bull Market Strengthened, Let The Naysayers Say Nay... September 15, 2024 Via Talk Markets Time To Invest And Or Trade In Bio-Tech Stocks? September 13, 2024 Via Talk Markets Topics ETFs 2 Unstoppable Growth Stocks to Buy Right Now for Less Than $500 September 13, 2024 Via The Motley Fool Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now September 12, 2024 Via The Motley Fool UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars September 11, 2024 Via Benzinga Viridian Spikes On A 'Bull-Case Scenario' For Eye Drug Considered Amgen Rival September 10, 2024 Via Investor's Business Daily Growth At Any Price (GAAP) Is A Bad Strategy. Valuation Matters. September 08, 2024 Via Talk Markets Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern September 05, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
